To better understand how ASTN can orchestrate intrahepatic immunity to influence HFD-induced progression of NASH and liver fibrosis, the frequency and cell number of liver non-parenchymal cells (NPCs) in HFD-fed mice were assessed by flow cytometry. This evidence concerns the gene ASTN1 and metabolic dysfunction-associated steatohepatitis.